A share price of CME Group Inc [CME] is currently trading at $261.39, down -0.56%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CME shares have gain 2.86% over the last week, with a monthly amount drifted -1.91%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on April 08, 2025, when Morgan Stanley upgraded its rating to a Overweight but kept the price target unchanged to $301 for it. Previously, Raymond James upgraded its rating to Outperform on March 10, 2025, and kept the price target unchanged to $287. On January 06, 2025, downgrade downgraded it’s rating to Neutral and revised its price target to $250 on the stock. Redburn Atlantic downgraded its rating to a Neutral but stick to its price target of $244 on October 08, 2024. RBC Capital Mkts initiated its recommendation with a Sector Perform and recommended $235 as its price target on September 27, 2024. TD Cowen started tracking with a Hold rating for this stock on September 26, 2024, and assigned it a price target of $221. In a note dated September 03, 2024, BofA Securities downgraded an Underperform rating on this stock and revised its target price from $212 to $177.
CME Group Inc experienced fluctuations in its stock price throughout the past year between $186.08 and $273.42. Currently, Wall Street analysts expect the stock to reach $258.67 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $261.39 at the most recent close of the market. An investor can expect a potential drop of -1.04% based on the average CME price forecast.
Analyzing the CME fundamentals
Trailing Twelve Months sales for CME Group Inc [NASDAQ:CME] were 6.13B which represents 5.98% growth. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at 0.64%, Pretax Profit Margin comes in at 0.74%, and Net Profit Margin reading is 0.57%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.13 and Total Capital is 0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 259.76 points at the first support level, and at 258.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 263.98, and for the 2nd resistance point, it is at 266.57.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 15.37, the price to book ratio is 3.55 and price to earnings (TTM) ratio is 27.02.
Transactions by insiders
Recent insider trading involved SHEPARD WILLIAM R, Director, that happened on Mar 26 ’25 when 263.0 shares were purchased. Director, SHEPARD WILLIAM R completed a deal on Mar 26 ’25 to buy 12.0 shares. Meanwhile, Director Lucas Deborah J sold 1500.0 shares on Mar 14 ’25.
